PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.\', \'Alan Turing Institute, London, UK.\', \'Departments of Medicine and Obstetrics and Gynecology, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, DC, USA.\', \'National Osteoporosis Foundation, Arlington, VA, USA.\', \'International Osteoporosis Foundation, Nyon, Switzerland.\', \'WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Liege, Belgium.\', \'Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.\', \'MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK. cc@mrc.soton.ac.uk.\', \'NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK. cc@mrc.soton.ac.uk.\', \'Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00198-020-05793-3
?:doi
?:hasPublicationType
?:journal
  • Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
is ?:pmid of
?:pmid
?:pmid
  • 33558957
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all